Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Update on docetaxel and breast cancer].
Diéras V, Girre V, Pierga JY, Laurence V, Piperno-Neumann S, Pouillart P. Diéras V, et al. Bull Cancer. 2004 May;91(5):409-17. Bull Cancer. 2004. PMID: 15281280 Free article. Review. French.
Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer.
Diéras V, Fumoleau P, Romieu G, Tubiana-Hulin M, Namer M, Mauriac L, Guastalla JP, Pujade-Lauraine E, Kerbrat P, Maillart P, Pénault-Llorca F, Buyse M, Pouillart P. Diéras V, et al. J Clin Oncol. 2004 Dec 15;22(24):4958-65. doi: 10.1200/JCO.2004.02.122. J Clin Oncol. 2004. PMID: 15611510 Clinical Trial.
[Oxaliplatin and ovarian cancer].
Dieras V, Girre V, Guilhaume MN, Laurence V, Mignot L. Dieras V, et al. Bull Cancer. 2006 Feb 1;93 Suppl 1:S35-9. Bull Cancer. 2006. PMID: 16483943 Review. French.
Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.
Bollet MA, Sigal-Zafrani B, Gambotti L, Extra JM, Meunier M, Nos C, Dendale R, Campana F, Kirova YM, Diéras V, Fourquet A; Institut Curie Breast Cancer Study Group. Bollet MA, et al. Among authors: dieras v. Eur J Cancer. 2006 Sep;42(14):2286-95. doi: 10.1016/j.ejca.2006.03.026. Epub 2006 Aug 8. Eur J Cancer. 2006. PMID: 16893641 Clinical Trial.
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
Milojkovic Kerklaan B, Diéras V, Le Tourneau C, Mergui-Roelvink M, Huitema AD, Rosing H, Beijnen JH, Marreaud S, Govaerts AS, Piccart-Gebhart MJ, Schellens JH, Awada A. Milojkovic Kerklaan B, et al. Among authors: dieras v. Cancer Chemother Pharmacol. 2013 Jan;71(1):53-62. doi: 10.1007/s00280-012-1972-1. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2013. PMID: 23053259 Clinical Trial.
290 results